Samuelsson B - Search Results

1

Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals.

Johansson A, Poliakov A, Akerblom E, Wiklund K, Lindeberg G, Winiwarter S, Danielson UH, Samuelsson B, Hallberg A. Johansson A, et al. Among authors: samuelsson b. Bioorg Med Chem. 2003 Jun 12;11(12):2551-68. doi: 10.1016/s0968-0896(03)00179-2. Bioorg Med Chem. 2003. PMID: 12757723

2

Tetrapeptides as potent protease inhibitors of Hepatitis C Virus full-length NS3 (protease-helicase/NTPase).

Johansson A, Poliakov A, Akerblom E, Lindeberg G, Winiwarter S, Samuelsson B, Danielson UH, Hallberg A. Johansson A, et al. Among authors: samuelsson b. Bioorg Med Chem. 2002 Dec;10(12):3915-22. doi: 10.1016/s0968-0896(02)00310-3. Bioorg Med Chem. 2002. PMID: 12413843

3

Relationships between structure and interaction kinetics for HIV-1 protease inhibitors.

Markgren PO, Schaal W, Hämäläinen M, Karlén A, Hallberg A, Samuelsson B, Danielson UH. Markgren PO, et al. Among authors: samuelsson b. J Med Chem. 2002 Dec 5;45(25):5430-9. doi: 10.1021/jm0208370. J Med Chem. 2002. PMID: 12459011

4

New potent C2-symmetric malaria plasmepsin I and II inhibitors.

Oscarsson K, Oscarson S, Vrang L, Hamelink E, Hallberg A, Samuelsson B. Oscarsson K, et al. Among authors: samuelsson b. Bioorg Med Chem. 2003 Apr 3;11(7):1235-46. doi: 10.1016/s0968-0896(02)00643-0. Bioorg Med Chem. 2003. PMID: 12628651

5

Peptide-based inhibitors of hepatitis C virus full-length NS3 (protease-helicase/NTPase): model compounds towards small molecule inhibitors.

Oscarsson K, Poliakov A, Oscarson S, Danielson UH, Hallberg A, Samuelsson B. Oscarsson K, et al. Among authors: samuelsson b. Bioorg Med Chem. 2003 Jul 3;11(13):2955-63. doi: 10.1016/s0968-0896(03)00190-1. Bioorg Med Chem. 2003. PMID: 12788365

6

New inhibitors of the malaria aspartyl proteases plasmepsin I and II.

Dahlgren A, Kvarnström I, Vrang L, Hamelink E, Hallberg A, Rosenquist A, Samuelsson B. Dahlgren A, et al. Among authors: samuelsson b. Bioorg Med Chem. 2003 Aug 5;11(16):3423-37. doi: 10.1016/s0968-0896(03)00312-2. Bioorg Med Chem. 2003. PMID: 12878137

7

C2-symmetric inhibitors of Plasmodium falciparum plasmepsin II: synthesis and theoretical predictions.

Ersmark K, Feierberg I, Bjelic S, Hultén J, Samuelsson B, Aqvist J, Hallberg A. Ersmark K, et al. Among authors: samuelsson b. Bioorg Med Chem. 2003 Aug 15;11(17):3723-33. doi: 10.1016/s0968-0896(03)00339-0. Bioorg Med Chem. 2003. PMID: 12901917

8

Structure-activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors.

Poliakov A, Johansson A, Akerblom E, Oscarsson K, Samuelsson B, Hallberg A, Danielson UH. Poliakov A, et al. Among authors: samuelsson b. Biochim Biophys Acta. 2004 Apr 7;1672(1):51-9. doi: 10.1016/j.bbagen.2004.02.008. Biochim Biophys Acta. 2004. PMID: 15056493

9

Cyclic sulfamide HIV-1 protease inhibitors, with sidechains spanning from P2/P2' to P1/P1'.

Ax A, Schaal W, Vrang L, Samuelsson B, Hallberg A, Karlén A. Ax A, et al. Among authors: samuelsson b. Bioorg Med Chem. 2005 Feb 1;13(3):755-64. doi: 10.1016/j.bmc.2004.10.042. Bioorg Med Chem. 2005. PMID: 15653343

10

A new structural theme in C2-symmetric HIV-1 protease inhibitors: ortho-substituted P1/P1' side chains.

Wannberg J, Sabnis YA, Vrang L, Samuelsson B, Karlén A, Hallberg A, Larhed M. Wannberg J, et al. Among authors: samuelsson b. Bioorg Med Chem. 2006 Aug 1;14(15):5303-15. doi: 10.1016/j.bmc.2006.03.045. Epub 2006 Apr 18. Bioorg Med Chem. 2006. PMID: 16621572

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

679 results

Search Page

Filters